Abstract
The generation of T lymphocytes with specific reactivity against tumor antigens is a prerequisite for effective adoptive transfer therapies. Melanoma-specific lymphocyte cultures can be established from tumor infiltrating lymphocytes (TILs) by in vitro culture in high levels of IL-2. We have optimized methods for generating melanoma-reactive TIL cultures from small resected tumor specimens. We report a retrospective analysis of 860 attempted TIL cultures from 90 sequential melanoma biopsy specimens from 62 HLA-A2+ patients. Multiple independent TIL derived from a single tumor often exhibited substantial functional and phenotypic variation. Tumor specific activity was detected in TIL from 29 (81%) of 36 patients screened. TIL cultures selected for high activity were generally capable of large numerical expansion using a single round of a rapid expansion protocol. Limited clonal T-cell populations in an oligoclonal TIL culture could confer specific tumor recognition in these highly selected, highly expanded TIL cultures. These methods were efficient at generating TILs suitable for adoptive transfer therapy.
MeSH Terms
Antigens/chemistry
CD4-Positive T-Lymphocytes/immunology
CD8-Positive T-Lymphocytes/immunology
Cell Separation
Cytokines/metabolism
Flow Cytometry
HLA-A2 Antigen/metabolism
Humans
Immunotherapy/methods
Immunotherapy, Adoptive/methods
Interleukin-2/biosynthesis,metabolism
Leukocytes, Mononuclear/metabolism
Lymphocytes, Tumor-Infiltrating/metabolism
Melanoma/immunology,metabolism,therapy
Phenotype
Receptors, Antigen, T-Cell/metabolism
Chemicals
Antigens
Cytokines
HLA-A2 Antigen
Interleukin-2
Receptors, Antigen, T-Cell
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Dudley Mark E
Surgery Branch, National Cancer Institute, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892-1502, USA.
[email protected]
Wunderlich John R
Shelton Thomas E
Even Jos
Rosenberg Steven A
References (17)
17 references, click to expand
-
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
J Immunol. 2000 Jul 15;165(2):948-55
PMID: 10878370
-
T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes.
Cancer J. 2000 Mar-Apr;6(2):69-77
PMID: 11069222
-
Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2.1 binding affinity and stability in solution.
J Immunother. 2001 Jan-Feb;24(1):1-9
PMID: 11211143
-
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.
J Immunother. 2001 Jul-Aug;24(4):363-73
PMID: 11565838
-
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.
J Immunother. 2002 May-Jun;25(3):243-51
PMID: 12000866
-
Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes.
J Immunother. 2002 May-Jun;25(3):252-63
PMID: 12000867
-
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.
Science. 2002 Oct 25;298(5594):850-4
PMID: 12242449
-
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16168-73
PMID: 12427970
-
Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.
Science. 1992 Jul 10;257(5067):238-41
PMID: 1352912
-
IMGT, the international ImMunoGeneTics information system for Immunoinformatics. Methods for querying IMGT databases, tools, and Web resources in the context of immunoinformatics.
Methods Mol Biol. 2007;409:19-42
PMID: 18449990
-
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
J Exp Med. 1994 Jul 1;180(1):347-52
PMID: 7516411
-
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.
J Natl Cancer Inst. 1994 Aug 3;86(15):1159-66
PMID: 8028037
-
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.
J Immunol. 1994 Sep 15;153(6):2807-18
PMID: 8077684
-
The extent of the human germline T-cell receptor V beta gene segment repertoire.
Immunogenetics. 1994;40(1):27-36
PMID: 8206523
-
Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience.
Int J Cancer. 1996 Feb 8;65(4):413-21
PMID: 8621219
-
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.
Blood. 1998 Sep 1;92(5):1549-55
PMID: 9716582
-
Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2).
Cancer Res. 1998 Nov 1;58(21):4895-901
PMID: 9809996